The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Transdermal Testosterone-Global Market Insights and Sales Trends 2025
Synopsis
Transdermal Testosterone contains testosterone. It is used for hormone replacement in men who are not able to produce enough testosterone (e.g., hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels.
The global Transdermal Testosterone market size is expected to reach US$ 923.9 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly driven by the significant applications of Transdermal Testosterone in various end use industries. The expanding demands from the Primary Hypogonadism, Hypogonadotropic Hypogonadism and Late-Onset Hypogonadism,, are propelling Transdermal Testosterone market. Gel, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Patch segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Transdermal Testosterone market, driven by demand from China, the second largest economy with some signs of stabilising, the Transdermal Testosterone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transdermal Testosterone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transdermal Testosterone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transdermal Testosterone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transdermal Testosterone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transdermal Testosterone covered in this report include AbbVie, Teva, Perrigo, Endo Pharmaceuticals, Acerus Pharmaceuticals, Lupin, Dr. Reddy's Laboratories, Upsher-Smith Laboratories and Allergan, etc.
The global Transdermal Testosterone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Teva
Perrigo
Endo Pharmaceuticals
Acerus Pharmaceuticals
Lupin
Dr. Reddy's Laboratories
Upsher-Smith Laboratories
Allergan
Cipla Inc.
Global Transdermal Testosterone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transdermal Testosterone market, Segment by Type:
Gel
Patch
Global Transdermal Testosterone market, by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Transdermal Testosterone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Transdermal Testosterone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Transdermal Testosterone contains testosterone. It is used for hormone replacement in men who are not able to produce enough testosterone (e.g., hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels.
The global Transdermal Testosterone market size is expected to reach US$ 923.9 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly driven by the significant applications of Transdermal Testosterone in various end use industries. The expanding demands from the Primary Hypogonadism, Hypogonadotropic Hypogonadism and Late-Onset Hypogonadism,, are propelling Transdermal Testosterone market. Gel, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Patch segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Transdermal Testosterone market, driven by demand from China, the second largest economy with some signs of stabilising, the Transdermal Testosterone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transdermal Testosterone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transdermal Testosterone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transdermal Testosterone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transdermal Testosterone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transdermal Testosterone covered in this report include AbbVie, Teva, Perrigo, Endo Pharmaceuticals, Acerus Pharmaceuticals, Lupin, Dr. Reddy's Laboratories, Upsher-Smith Laboratories and Allergan, etc.
The global Transdermal Testosterone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Teva
Perrigo
Endo Pharmaceuticals
Acerus Pharmaceuticals
Lupin
Dr. Reddy's Laboratories
Upsher-Smith Laboratories
Allergan
Cipla Inc.
Global Transdermal Testosterone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transdermal Testosterone market, Segment by Type:
Gel
Patch
Global Transdermal Testosterone market, by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Transdermal Testosterone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Transdermal Testosterone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Transdermal Testosterone Market Overview
1.1 Transdermal Testosterone Product Overview
1.2 Transdermal Testosterone Market Segment by Type
1.2.1 Gel
1.2.2 Patch
1.3 Global Transdermal Testosterone Market Size by Type
1.3.1 Global Transdermal Testosterone Market Size Overview by Type (2018-2029)
1.3.2 Global Transdermal Testosterone Historic Market Size Review by Type (2018-2023)
1.3.3 Global Transdermal Testosterone Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Transdermal Testosterone Sales Breakdown by Type (2018-2023)
1.4.2 Europe Transdermal Testosterone Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Transdermal Testosterone Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Transdermal Testosterone Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Transdermal Testosterone Sales Breakdown by Type (2018-2023)
2 Global Transdermal Testosterone Market Competition by Company
2.1 Global Top Players by Transdermal Testosterone Sales (2018-2023)
2.2 Global Top Players by Transdermal Testosterone Revenue (2018-2023)
2.3 Global Top Players by Transdermal Testosterone Price (2018-2023)
2.4 Global Top Manufacturers Transdermal Testosterone Manufacturing Base Distribution, Sales Area, Product Type
2.5 Transdermal Testosterone Market Competitive Situation and Trends
2.5.1 Transdermal Testosterone Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Transdermal Testosterone Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Testosterone as of 2022)
2.7 Date of Key Manufacturers Enter into Transdermal Testosterone Market
2.8 Key Manufacturers Transdermal Testosterone Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Transdermal Testosterone Status and Outlook by Region
3.1 Global Transdermal Testosterone Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Transdermal Testosterone Historic Market Size by Region
3.2.1 Global Transdermal Testosterone Sales in Volume by Region (2018-2023)
3.2.2 Global Transdermal Testosterone Sales in Value by Region (2018-2023)
3.2.3 Global Transdermal Testosterone Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Transdermal Testosterone Forecasted Market Size by Region
3.3.1 Global Transdermal Testosterone Sales in Volume by Region (2024-2029)
3.3.2 Global Transdermal Testosterone Sales in Value by Region (2024-2029)
3.3.3 Global Transdermal Testosterone Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Transdermal Testosterone by Application
4.1 Transdermal Testosterone Market Segment by Application
4.1.1 Primary Hypogonadism
4.1.2 Hypogonadotropic Hypogonadism
4.1.3 Late-Onset Hypogonadism
4.2 Global Transdermal Testosterone Market Size by Application
4.2.1 Global Transdermal Testosterone Market Size Overview by Application (2018-2029)
4.2.2 Global Transdermal Testosterone Historic Market Size Review by Application (2018-2023)
4.2.3 Global Transdermal Testosterone Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Transdermal Testosterone Sales Breakdown by Application (2018-2023)
4.3.2 Europe Transdermal Testosterone Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Transdermal Testosterone Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Transdermal Testosterone Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Transdermal Testosterone Sales Breakdown by Application (2018-2023)
5 North America Transdermal Testosterone by Country
5.1 North America Transdermal Testosterone Historic Market Size by Country
5.1.1 North America Transdermal Testosterone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Transdermal Testosterone Sales in Volume by Country (2018-2023)
5.1.3 North America Transdermal Testosterone Sales in Value by Country (2018-2023)
5.2 North America Transdermal Testosterone Forecasted Market Size by Country
5.2.1 North America Transdermal Testosterone Sales in Volume by Country (2024-2029)
5.2.2 North America Transdermal Testosterone Sales in Value by Country (2024-2029)
6 Europe Transdermal Testosterone by Country
6.1 Europe Transdermal Testosterone Historic Market Size by Country
6.1.1 Europe Transdermal Testosterone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Transdermal Testosterone Sales in Volume by Country (2018-2023)
6.1.3 Europe Transdermal Testosterone Sales in Value by Country (2018-2023)
6.2 Europe Transdermal Testosterone Forecasted Market Size by Country
6.2.1 Europe Transdermal Testosterone Sales in Volume by Country (2024-2029)
6.2.2 Europe Transdermal Testosterone Sales in Value by Country (2024-2029)
7 Asia-Pacific Transdermal Testosterone by Region
7.1 Asia-Pacific Transdermal Testosterone Historic Market Size by Region
7.1.1 Asia-Pacific Transdermal Testosterone Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Transdermal Testosterone Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Transdermal Testosterone Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Transdermal Testosterone Forecasted Market Size by Region
7.2.1 Asia-Pacific Transdermal Testosterone Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Transdermal Testosterone Sales in Value by Region (2024-2029)
8 Latin America Transdermal Testosterone by Country
8.1 Latin America Transdermal Testosterone Historic Market Size by Country
8.1.1 Latin America Transdermal Testosterone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Transdermal Testosterone Sales in Volume by Country (2018-2023)
8.1.3 Latin America Transdermal Testosterone Sales in Value by Country (2018-2023)
8.2 Latin America Transdermal Testosterone Forecasted Market Size by Country
8.2.1 Latin America Transdermal Testosterone Sales in Volume by Country (2024-2029)
8.2.2 Latin America Transdermal Testosterone Sales in Value by Country (2024-2029)
9 Middle East and Africa Transdermal Testosterone by Country
9.1 Middle East and Africa Transdermal Testosterone Historic Market Size by Country
9.1.1 Middle East and Africa Transdermal Testosterone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Transdermal Testosterone Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Transdermal Testosterone Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Transdermal Testosterone Forecasted Market Size by Country
9.2.1 Middle East and Africa Transdermal Testosterone Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Transdermal Testosterone Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AbbVie
10.1.1 AbbVie Company Information
10.1.2 AbbVie Introduction and Business Overview
10.1.3 AbbVie Transdermal Testosterone Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AbbVie Transdermal Testosterone Products Offered
10.1.5 AbbVie Recent Development
10.2 Teva
10.2.1 Teva Company Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Transdermal Testosterone Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Teva Transdermal Testosterone Products Offered
10.2.5 Teva Recent Development
10.3 Perrigo
10.3.1 Perrigo Company Information
10.3.2 Perrigo Introduction and Business Overview
10.3.3 Perrigo Transdermal Testosterone Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Perrigo Transdermal Testosterone Products Offered
10.3.5 Perrigo Recent Development
10.4 Endo Pharmaceuticals
10.4.1 Endo Pharmaceuticals Company Information
10.4.2 Endo Pharmaceuticals Introduction and Business Overview
10.4.3 Endo Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Endo Pharmaceuticals Transdermal Testosterone Products Offered
10.4.5 Endo Pharmaceuticals Recent Development
10.5 Acerus Pharmaceuticals
10.5.1 Acerus Pharmaceuticals Company Information
10.5.2 Acerus Pharmaceuticals Introduction and Business Overview
10.5.3 Acerus Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Acerus Pharmaceuticals Transdermal Testosterone Products Offered
10.5.5 Acerus Pharmaceuticals Recent Development
10.6 Lupin
10.6.1 Lupin Company Information
10.6.2 Lupin Introduction and Business Overview
10.6.3 Lupin Transdermal Testosterone Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Lupin Transdermal Testosterone Products Offered
10.6.5 Lupin Recent Development
10.7 Dr. Reddy's Laboratories
10.7.1 Dr. Reddy's Laboratories Company Information
10.7.2 Dr. Reddy's Laboratories Introduction and Business Overview
10.7.3 Dr. Reddy's Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Dr. Reddy's Laboratories Transdermal Testosterone Products Offered
10.7.5 Dr. Reddy's Laboratories Recent Development
10.8 Upsher-Smith Laboratories
10.8.1 Upsher-Smith Laboratories Company Information
10.8.2 Upsher-Smith Laboratories Introduction and Business Overview
10.8.3 Upsher-Smith Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Upsher-Smith Laboratories Transdermal Testosterone Products Offered
10.8.5 Upsher-Smith Laboratories Recent Development
10.9 Allergan
10.9.1 Allergan Company Information
10.9.2 Allergan Introduction and Business Overview
10.9.3 Allergan Transdermal Testosterone Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Allergan Transdermal Testosterone Products Offered
10.9.5 Allergan Recent Development
10.10 Cipla Inc.
10.10.1 Cipla Inc. Company Information
10.10.2 Cipla Inc. Introduction and Business Overview
10.10.3 Cipla Inc. Transdermal Testosterone Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Cipla Inc. Transdermal Testosterone Products Offered
10.10.5 Cipla Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Transdermal Testosterone Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Transdermal Testosterone Industrial Chain Analysis
11.4 Transdermal Testosterone Market Dynamics
11.4.1 Transdermal Testosterone Industry Trends
11.4.2 Transdermal Testosterone Market Drivers
11.4.3 Transdermal Testosterone Market Challenges
11.4.4 Transdermal Testosterone Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Transdermal Testosterone Distributors
12.3 Transdermal Testosterone Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
